Clinical Trials for Femoral Hernia
Currently, there is one ongoing clinical trial investigating the use of antibiotic prophylaxis in patients undergoing surgery for inguinal or femoral hernia. This trial is being conducted in Spain and aims to determine whether antibiotics are necessary to prevent infections after hernia repair surgery.
Clinical trial locations
Study on the Necessity of Cefazolin in Preventing Infections After Inguinal or Femoral Hernia Surgery
This clinical trial is exploring whether the use of antibiotics during hernia repair surgery is truly necessary to prevent infections at the surgical site. The study focuses on patients undergoing surgery for inguinal or femoral hernias, which are conditions where tissue pushes through weak spots in the groin area.
Main inclusion criteria:
- Men or women over 18 years of age
- Patients diagnosed with inguinal or femoral hernias in the groin area
- Patients with recurrent hernias, meaning the hernia has returned after previous treatment
- Willingness and ability to attend scheduled follow-up visits
- Ability to provide informed consent, which is a signed document confirming understanding of and agreement to participate in the study
Main exclusion criteria:
- Patients outside the specified age range for the study
- Individuals who belong to vulnerable populations that may require special protection or care
Focus and goal of the trial:
The primary goal of this study is to determine whether giving antibiotics before surgery is as effective as not using them in preventing infections after hernia repair. Participants will be divided into two groups: one group will receive the antibiotic cefazolin during their surgery, while the other group will receive a placebo. After surgery, all participants will be carefully monitored for any signs of infection at the surgical site. The study will compare the outcomes between both groups to see if antibiotics make a meaningful difference in preventing post-surgical infections.
Investigational treatment:
The study uses cefazolin, a type of antibiotic commonly used to prevent infections during surgical procedures. Cefazolin works by targeting and stopping the growth of bacteria, either by disrupting their cell wall or interfering with their ability to produce proteins. In this trial, cefazolin is administered intravenously as a solution for injection during the hernia repair surgery. The researchers aim to provide evidence on whether this antibiotic prophylaxis is essential for all patients undergoing this type of surgery, which could potentially lead to changes in standard medical practices.
The trial is expected to continue collecting data until the end of 2025, with participants attending scheduled follow-up visits to evaluate their recovery and monitor for any potential complications.
Summary
There is currently one active clinical trial related to femoral and inguinal hernia surgery, taking place in Spain. This study is investigating the necessity of antibiotic prophylaxis, specifically the use of cefazolin, in preventing surgical site infections following hernia repair. The trial’s findings may have important implications for surgical practices, potentially reducing unnecessary antibiotic use if the results show that antibiotics are not essential for infection prevention in this patient population. Patients interested in participating should be over 18 years of age and willing to comply with follow-up requirements.
